Community end user perceptions of hessian fabric transfluthrin vapour emanators for protecting against mosquitoes under conditions of routine use in Port-au-Prince, Haiti.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 16 05 2023
accepted: 27 02 2024
medline: 10 7 2024
pubmed: 10 7 2024
entrez: 10 7 2024
Statut: epublish

Résumé

A treated fabric device for emanating the volatile pyrethroid transfluthrin was recently developed in Tanzania that protected against night-biting Anopheles and Culex mosquitoes for several months. Here perceptions of community end users provided with such transfluthrin emanators, primarily intended to protect them against day-active Aedes vectors of human arboviruses that often attack people outdoors, were assessed in Port-au-Prince, Haiti. Following the distribution of transfluthrin emanators to participating households in poor-to-middle class urban neighbourhoods, questionnaire surveys and in-depth interviews of end-user households were supplemented with conventional and Photovoice-based focus group discussions. Observations were assessed synthetically to evaluate user perceptions of protection and acceptability, and to solicit advice for improving and promoting them in the future. Many participants viewed emanators positively and several outlined various advantages over current alternatives, although some expressed concerns about smell, health hazards, bulkiness, unattractiveness and future cost. Most participants expressed moderate to high satisfaction with protection against mosquitoes, especially indoors. Protection against other arthropod pests was also commonly reported, although satisfaction levels were highly variable. Diverse use practices were reported, some of which probably targeted nocturnal Culex resting indoors, rather than Aedes attacking them outdoors during daylight hours. Perceived durability of protection varied: While many participants noted some slow loss over months, others noted rapid decline within days. A few participants specifically attributed efficacy loss to outdoor use and exposure to wind or moisture. Many expressed stringent expectations of satisfactory protection levels, with even a single mosquito bite considered unsatisfactory. Some participants considered emanators superior to fans, bedsheets, sprays and coils, but it is concerning that several preferred them to bed nets and consequently stopped using the latter. The perspectives shared by Haitian end-users are consistent with those from similar studies in Brazil and recent epidemiological evidence from Peru that other transfluthrin emanator products can protect against arbovirus infection. While these encouraging sociological observations contrast starkly with evidence of essentially negligible effects upon Aedes landing rates from parallel entomological assessments across Haiti, Tanzania, Brazil and Peru, no other reason to doubt the generally encouraging views expressed herein by Haitian end users could be identified.

Sections du résumé

BACKGROUND BACKGROUND
A treated fabric device for emanating the volatile pyrethroid transfluthrin was recently developed in Tanzania that protected against night-biting Anopheles and Culex mosquitoes for several months. Here perceptions of community end users provided with such transfluthrin emanators, primarily intended to protect them against day-active Aedes vectors of human arboviruses that often attack people outdoors, were assessed in Port-au-Prince, Haiti.
METHODS METHODS
Following the distribution of transfluthrin emanators to participating households in poor-to-middle class urban neighbourhoods, questionnaire surveys and in-depth interviews of end-user households were supplemented with conventional and Photovoice-based focus group discussions. Observations were assessed synthetically to evaluate user perceptions of protection and acceptability, and to solicit advice for improving and promoting them in the future.
RESULTS RESULTS
Many participants viewed emanators positively and several outlined various advantages over current alternatives, although some expressed concerns about smell, health hazards, bulkiness, unattractiveness and future cost. Most participants expressed moderate to high satisfaction with protection against mosquitoes, especially indoors. Protection against other arthropod pests was also commonly reported, although satisfaction levels were highly variable. Diverse use practices were reported, some of which probably targeted nocturnal Culex resting indoors, rather than Aedes attacking them outdoors during daylight hours. Perceived durability of protection varied: While many participants noted some slow loss over months, others noted rapid decline within days. A few participants specifically attributed efficacy loss to outdoor use and exposure to wind or moisture. Many expressed stringent expectations of satisfactory protection levels, with even a single mosquito bite considered unsatisfactory. Some participants considered emanators superior to fans, bedsheets, sprays and coils, but it is concerning that several preferred them to bed nets and consequently stopped using the latter.
CONCLUSIONS CONCLUSIONS
The perspectives shared by Haitian end-users are consistent with those from similar studies in Brazil and recent epidemiological evidence from Peru that other transfluthrin emanator products can protect against arbovirus infection. While these encouraging sociological observations contrast starkly with evidence of essentially negligible effects upon Aedes landing rates from parallel entomological assessments across Haiti, Tanzania, Brazil and Peru, no other reason to doubt the generally encouraging views expressed herein by Haitian end users could be identified.

Identifiants

pubmed: 38985752
doi: 10.1371/journal.pone.0300368
pii: PONE-D-23-12193
doi:

Substances chimiques

Fluorobenzenes 0
transfluthrin QWL3SKA6EG
Cyclopropanes 0
Insecticides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0300368

Informations de copyright

Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Déclaration de conflit d'intérêts

JM was employed by Bayer/Envu AG at the time of the study, which manufactured all the transfluthrin formulations that were used in this study. Otherwise, all the other authors declare that they have no competing interests. This does not alter our adherence to PLoS One policies on sharing data and materials.

Auteurs

Obrillant Damus (O)

Université Quisqueya, Port-au-Prince, Republic of Haiti.

Chicoye Supreme (C)

Université Quisqueya, Port-au-Prince, Republic of Haiti.

Jean-Frantz Lemoine (JF)

Programme National de Contrôle de la Malaria, Ministère de la Santé Publique et de la Population, Port-au-Prince, Republic of Haiti.

Christian Raccurt (C)

Université Quisqueya, Port-au-Prince, Republic of Haiti.

Justin McBeath (J)

Envu UK Ltd, Milton, Cambridge, United Kingdom.

Sheila B Ogoma (SB)

Abt Associates, Nairobi, Kenya.

Vincent Corbel (V)

Institut de Recherche pour le Developpement, Infectious Diseases and Vectors-Ecology, Genetics, Evolution and Control (MIVEGEC) Unit, University of Montpellier, Montpellier, France.
Laboratório de Fisiologia e Controle de Artrópodes Vetores (Laficave), Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro-RJ, Brazil.

Katherine Andrinopoulos (K)

Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana, United States of America.

Daniel Impoinvil (D)

Entomology Division, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.

Gerry F Killeen (GF)

Environmental Health and Ecological Sciences Department, Ifakara Health Institute, Morogoro, United Republic of Tanzania.
Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
School of Biological Earth & Environmental Sciences, Environmental Research Institute, University College Cork, Cork, Republic of Ireland.

Cyrille Czeher (C)

Institut de Recherche pour le Developpement, Infectious Diseases and Vectors-Ecology, Genetics, Evolution and Control (MIVEGEC) Unit, University of Montpellier, Montpellier, France.
Entente Interdépartementale pour la Démoustication du Littoral Méditerranéen (EID Méditerranée), Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH